Keros Therapeutics, Inc. · NASDAQ:KROS
Prener Anne received 13,786 Keros Therapeutics, Inc. shares as an award (Form 4)
Traded Jul 1, 2026 · Filed Jul 6, 2026
On Jul 1, 2026, Prener Anne (Director) received 13,786 Keros Therapeutics, Inc. shares as an award, leaving 13,786 shares. Filed Jul 6, 2026 (Form 4).
- Awarded
- 13,786 shares
- Holding after
- 13,786 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Common Stock | Award | 13,786 | 13,786 | Direct |